“Gencia LLC and Takeda Pharmaceutical Company Limited announced today a partnership to develop a new class of small molecule drugs as potential treatments for hematological and inflammatory diseases. Called Mitochondrial Agonists of the Glucocorticoid Receptor (MAGR), such compounds may offer the
“Gencia LLC and Takeda Pharmaceutical Company Limited announced today a partnership to develop a new class of small molecule drugs as potential treatments for hematological and inflammatory diseases. Called Mitochondrial Agonists of the Glucocorticoid Receptor (MAGR), such compounds may offer the
このブックマークにはスターがありません。
最初のスターをつけてみよう！
Gencia and Takeda Team to Discover and Develop Novel Class of Mitochondrial Therapeutics
1 人がブックマーク・1 件のコメント
＼ コメントが サクサク読める アプリです ／